401 related articles for article (PubMed ID: 11741943)
1. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
Mendrola JM; Berger MB; King MC; Lemmon MA
J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
[TBL] [Abstract][Full Text] [Related]
2. Dimerization of the transmembrane domain of Integrin alphaIIb subunit in cell membranes.
Li R; Gorelik R; Nanda V; Law PB; Lear JD; DeGrado WF; Bennett JS
J Biol Chem; 2004 Jun; 279(25):26666-73. PubMed ID: 15067009
[TBL] [Abstract][Full Text] [Related]
3. Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization.
Gerber D; Sal-Man N; Shai Y
J Biol Chem; 2004 May; 279(20):21177-82. PubMed ID: 14985340
[TBL] [Abstract][Full Text] [Related]
4. [Bacterial synthesis, purification, and solubilization of transmembrane segments of ErbB family members].
Goncharuk MV; Shul'ga AA; Ermoliuk IaS; Tkach EN; Goncharuk SA; Pustovalova IuE; Mineev KS; Bocharov ÉV; Maslennikov IV; Arsen'ev AS; Kirpichnikov MP
Mol Biol (Mosk); 2011; 45(5):892-902. PubMed ID: 22393787
[TBL] [Abstract][Full Text] [Related]
5. Two GxxxG-like motifs facilitate promiscuous interactions of the human ErbB transmembrane domains.
Escher C; Cymer F; Schneider D
J Mol Biol; 2009 May; 389(1):10-6. PubMed ID: 19361517
[TBL] [Abstract][Full Text] [Related]
6. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
7. Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant.
Beevers AJ; Damianoglou A; Oates J; Rodger A; Dixon AM
Biochemistry; 2010 Apr; 49(13):2811-20. PubMed ID: 20180588
[TBL] [Abstract][Full Text] [Related]
8. The transmembrane domains of ErbB receptors do not dimerize strongly in micelles.
Stanley AM; Fleming KG
J Mol Biol; 2005 Apr; 347(4):759-72. PubMed ID: 15769468
[TBL] [Abstract][Full Text] [Related]
9. Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.
Franco-Gonzalez JF; Ramos J; Cruz VL; Martínez-Salazar J
J Mol Model; 2013 Feb; 19(2):931-41. PubMed ID: 23090500
[TBL] [Abstract][Full Text] [Related]
10. Evidence for new homotypic and heterotypic interactions between transmembrane helices of proteins involved in receptor tyrosine kinase and neuropilin signaling.
Sawma P; Roth L; Blanchard C; Bagnard D; Crémel G; Bouveret E; Duneau JP; Sturgis JN; Hubert P
J Mol Biol; 2014 Dec; 426(24):4099-4111. PubMed ID: 25315821
[TBL] [Abstract][Full Text] [Related]
11. TOXCAT: a measure of transmembrane helix association in a biological membrane.
Russ WP; Engelman DM
Proc Natl Acad Sci U S A; 1999 Feb; 96(3):863-8. PubMed ID: 9927659
[TBL] [Abstract][Full Text] [Related]
12. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
13. Insights into the transmembrane helix associations of kit ligand by molecular dynamics simulation and TOXCAT.
Chai M; Liu B; Sun F; Wei P; Chen P; Xu L; Luo SZ
Proteins; 2017 Jul; 85(7):1362-1370. PubMed ID: 28370370
[TBL] [Abstract][Full Text] [Related]
14. Disabling receptor ensembles with rationally designed interface peptidomimetics.
Berezov A; Chen J; Liu Q; Zhang HT; Greene MI; Murali R
J Biol Chem; 2002 Aug; 277(31):28330-9. PubMed ID: 12011054
[TBL] [Abstract][Full Text] [Related]
15. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
Muthuswamy SK; Gilman M; Brugge JS
Mol Cell Biol; 1999 Oct; 19(10):6845-57. PubMed ID: 10490623
[TBL] [Abstract][Full Text] [Related]
16. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS
J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394
[TBL] [Abstract][Full Text] [Related]
17. The ErbB/HER receptor protein-tyrosine kinases and cancer.
Roskoski R
Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by transmembrane peptides of chimeric insulin receptors.
Bennasroune A; Gardin A; Auzan C; Clauser E; Dirrig-Grosch S; Meira M; Appert-Collin A; Aunis D; Crémel G; Hubert P
Cell Mol Life Sci; 2005 Sep; 62(18):2124-31. PubMed ID: 16132228
[TBL] [Abstract][Full Text] [Related]
19. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.
Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C
J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710
[TBL] [Abstract][Full Text] [Related]
20. Val(659)-->Glu mutation within the transmembrane domain of ErbB-2: effects measured by (2)H NMR in fluid phospholipid bilayers.
Sharpe S; Barber KR; Grant CW
Biochemistry; 2000 May; 39(21):6572-80. PubMed ID: 10828974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]